Precision Medicine Group

Precision Medicine Group is a global professional services firm serving pharmaceutical, biotechnology and life-sciences clients on product development and commercialization. Founded in 2012, the company employs some 3,500 people across an integrated team of specialists in advanced lab sciences, translational informatics, regulatory affairs, payer insights and marketing communications.

The firm operates through two groups. Precision for Medicine provides biomarker-driven research and development services. Precision AQ provides commercialization services, supporting life-sciences organizations from product launch through maturity. Together they cover work spanning biomarker-driven R&D and data analytics alongside commercial disciplines.

Employment at the company spans scientific and commercial functions, from laboratory sciences and informatics to regulatory, market access and communications roles. The organization works with clients in pharmaceuticals, biotechnology and drug development, and describes itself as a single multidisciplinary team rather than a set of separate practices.

Precision Medicine Group states that it was founded on the belief that there is a transformational opportunity to improve the drug development process. It maintains a global presence.